0001288123-18-000022.txt : 20180702 0001288123-18-000022.hdr.sgml : 20180702 20180702154344 ACCESSION NUMBER: 0001288123-18-000022 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180620 FILED AS OF DATE: 20180702 DATE AS OF CHANGE: 20180702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLASKIN CHRISTINE M CENTRAL INDEX KEY: 0001288123 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 18932561 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0306 4/A 2018-06-20 2018-06-22 0 0001098972 AGENUS INC AGEN 0001288123 KLASKIN CHRISTINE M 3 FORBES ROAD LEXINGTON MA 02421 0 1 0 0 VP Finance Stock Option, right to buy 5.65 2018-06-20 4 A 0 83150 5.65 A 2019-03-02 2028-03-02 Common Stock 83150 83150 D Option was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Options awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, and vests over three years with one-third of the award vesting on march 2, 2019 and the balance vesting in equal quarterly installments thereafter. Amendment filed to correct previously reported expiration date of the award. Christine M. Klaskin 2018-07-02